Preparation and Characterization of Mefenamic Acid Microcapsule using Sodium Alginate Polymer by Ionic Gelation Methods

Authors

  • Sandra Aulia Mardikasari Fakultas Farmasi, Universitas Hasanuddin ,
  • Suryani Suryani Fakultas Farmasi, Universitas Halu Oleo ,
  • Marwah Puspitasari Fakultas Farmasi, Universitas Halu Oleo ,

DOI:

https://doi.org/10.35814/jifi.v18i2.797

Keywords:

Microencapsulation, microcapsule, mefenamic acid, entrapment efficiency, NSAID

Abstract

Mefenamic acid belongs to a class of the non-steroidal anti-infl ammatory drugs that work as
an analgesic. Mefenamic acid is sensitive to the light and temperature, also has unpleasant odors and
tastes. Microencapsulation technology is a technique where the active substance is coated by a thin layer
so that the active substance is protected from environmental infl uences. The aim of this research was to
formulate and characterize mefenamic acid in the form of microcapsule using ionic gelation methods
with sodium alginate. Preparation was done by comparing the concentrations of sodium alginate
polymers namely, 1%, 2%, and 3%. Success parameters include the entrapment effi ciency, particle
shape, particle size distribution, and dissolution. The results on the entrapment effi ciency using UVVIS
spectrophotometer showed a concentration of 1% polymer has a high value of 94.02%, for particle
shapes using the optical microscope showed that three formulas were spherical with the smallest particle
size distribution was 1266 μm. The dissolution test by type II dissolution test showed that the higher
the concentration of polymer used, the slower the drug release. This research provides an alternative
formulation of mefenamic acid microcapsule by using sodium alginate polymer.

References

Downloads

Published

2020-10-28

Issue

Vol. 18 No. 2 (2020): JIFI

Section

Articles

License

Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.

This licence applies to Author(s) and Public Reader means that the users mays :

  • SHARE:
    copy and redistribute the article in any medium or format
  • ADAPT:
    remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication)
  • ALIKE:
    If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original.
  • NO ADDITIONAL RESTRICTIONS:
    You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

It does however mean that when you use it you must:

  • ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

You may not:

  • NONCOMMERCIAL: You may not use the article for commercial purposes.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.